Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis.


Journal

Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946

Informations de publication

Date de publication:
05 2020
Historique:
received: 04 03 2019
accepted: 26 08 2019
pubmed: 11 9 2019
medline: 21 4 2021
entrez: 11 9 2019
Statut: ppublish

Résumé

Activated hepatocytes are hypothesized to be a major source of signals that drive cirrhosis, but the biochemical pathways that convert hepatocytes into such a state are unclear. We examined the role of the Hippo pathway transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) in hepatocytes to facilitate cell-cell interactions that stimulate liver inflammation and fibrosis. Using a variety of genetic, metabolic, and liver injury models in mice, we manipulated Hippo signaling in hepatocytes and examined its effects in nonparenchymal cells to promote liver inflammation and fibrosis. YAP-expressing hepatocytes rapidly and potently activate the expression of proteins that promote fibrosis (collagen type I alpha 1 chain, tissue inhibitor of metalloproteinase 1, platelet-derived growth factor c, transforming growth factor β2) and inflammation (tumor necrosis factor, interleukin 1β). They stimulate expansion of myofibroblasts and immune cells, followed by aggressive liver fibrosis. In contrast, hepatocyte-specific YAP and YAP/TAZ knockouts exhibit limited myofibroblast expansion, less inflammation, and decreased fibrosis after CCl Liver injury in mice and humans increases levels of YAP/TAZ/CYR61 in hepatocytes, thus attracting macrophages to the liver to promote inflammation and fibrosis.

Sections du résumé

BACKGROUND AND AIMS
Activated hepatocytes are hypothesized to be a major source of signals that drive cirrhosis, but the biochemical pathways that convert hepatocytes into such a state are unclear. We examined the role of the Hippo pathway transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) in hepatocytes to facilitate cell-cell interactions that stimulate liver inflammation and fibrosis.
APPROACH AND RESULTS
Using a variety of genetic, metabolic, and liver injury models in mice, we manipulated Hippo signaling in hepatocytes and examined its effects in nonparenchymal cells to promote liver inflammation and fibrosis. YAP-expressing hepatocytes rapidly and potently activate the expression of proteins that promote fibrosis (collagen type I alpha 1 chain, tissue inhibitor of metalloproteinase 1, platelet-derived growth factor c, transforming growth factor β2) and inflammation (tumor necrosis factor, interleukin 1β). They stimulate expansion of myofibroblasts and immune cells, followed by aggressive liver fibrosis. In contrast, hepatocyte-specific YAP and YAP/TAZ knockouts exhibit limited myofibroblast expansion, less inflammation, and decreased fibrosis after CCl
CONCLUSIONS
Liver injury in mice and humans increases levels of YAP/TAZ/CYR61 in hepatocytes, thus attracting macrophages to the liver to promote inflammation and fibrosis.

Identifiants

pubmed: 31505040
doi: 10.1002/hep.30928
pmc: PMC7062580
mid: NIHMS1049647
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
COL1A1 protein, human 0
Cell Cycle Proteins 0
Collagen Type I, alpha 1 Chain 0
Cysteine-Rich Protein 61 0
Trans-Activators 0
Transcription Factors 0
Transcriptional Coactivator with PDZ-Binding Motif Proteins 0
WWTR1 protein, human 0
Wwtr1 protein, mouse 0
YAP-Signaling Proteins 0
YY1AP1 protein, human 0
Yap1 protein, mouse 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1813-1830

Subventions

Organisme : NIDDK NIH HHS
ID : K08 DK105351
Pays : United States
Organisme : NIBIB NIH HHS
ID : T32 EB001026
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01DK033201
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK120531
Pays : United States
Organisme : NIDDK NIH HHS
ID : 2P30DK034854
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK036836
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01DK031036
Pays : United States
Organisme : NIH HHS
ID : K08 DK105351
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK033201
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR025758
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK031036
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA183119
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01DK099559
Pays : United States
Organisme : NICHD NIH HHS
ID : K12 HD000850
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30DK40561
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK034854
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK099559
Pays : United States
Organisme : NCI NIH HHS
ID : R01CA183119
Pays : United States
Organisme : NIDDK NIH HHS
ID : R37 DK031036
Pays : United States
Organisme : NIH HHS
ID : UL1RR025758
Pays : United States
Organisme : NICHD NIH HHS
ID : K12HD000850
Pays : United States

Informations de copyright

© 2019 by the American Association for the Study of Liver Diseases.

Références

Cell. 2014 Feb 27;156(5):893-906
pubmed: 24581491
Hepatology. 2009 Jul;50(1):261-74
pubmed: 19554540
Gastroenterology. 2017 Feb;152(3):533-545
pubmed: 28003097
Nat Cell Biol. 2016 Aug;18(8):886-896
pubmed: 27428308
Cell Metab. 2016 Dec 13;24(6):848-862
pubmed: 28068223
Nat Immunol. 2017 Jul;18(7):733-743
pubmed: 28481329
Genes Dev. 2013 Apr 1;27(7):719-24
pubmed: 23520387
Cell. 2007 Sep 21;130(6):1120-33
pubmed: 17889654
Hepatology. 2012 Sep;56(3):1097-107
pubmed: 22886419
Sci Rep. 2016 Jan 14;6:19275
pubmed: 26763940
Nat Cell Biol. 2015 Aug;17(8):971-983
pubmed: 26192438
Gastroenterology. 2017 Mar;152(4):745-761
pubmed: 28043904
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13839-44
pubmed: 23918388
J Clin Invest. 2018 Mar 1;128(3):1010-1025
pubmed: 29400692
Hum Pathol. 2014 May;45(5):1057-64
pubmed: 24746211
J Biol Chem. 2008 Oct 10;283(41):27534-46
pubmed: 18640976
Gastroenterology. 2017 Jun;152(8):2037-2051.e22
pubmed: 28249813
Diabetes. 2016 Aug;65(8):2187-200
pubmed: 27207510
Gastroenterology. 2014 Sep;147(3):577-594.e1
pubmed: 25066692
Nat Cell Biol. 2012 Dec;14(12):1322-9
pubmed: 23143395
Nat Cell Biol. 2017 Apr;19(4):362-374
pubmed: 28346439
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12405-10
pubmed: 16894141
J Hepatol. 2013 Sep;59(3):583-94
pubmed: 23567086
Cell Rep. 2015 Apr 14;11(2):270-82
pubmed: 25843714
Natl Vital Stat Rep. 2017 Nov;66(6):1-75
pubmed: 29235985
Cell. 2014 Jun 5;157(6):1324-38
pubmed: 24906150
Genes Dev. 2007 Nov 1;21(21):2747-61
pubmed: 17974916
Gastroenterology. 2012 Nov;143(5):1158-1172
pubmed: 22982943
Sci Transl Med. 2013 Jan 9;5(167):167sr1
pubmed: 23303606
Cancer Res. 2011 Apr 1;71(7):2728-38
pubmed: 21349946
J Hepatol. 2015 Oct;63(4):962-70
pubmed: 26070409
Cell. 2011 Mar 4;144(5):782-95
pubmed: 21376238
Genes Dev. 2008 Jul 15;22(14):1962-71
pubmed: 18579750
Cell Res. 2011 Jan;21(1):159-68
pubmed: 21187858
Cell. 2015 Nov 5;163(4):811-28
pubmed: 26544935
Nat Rev Immunol. 2014 Mar;14(3):181-94
pubmed: 24566915
Mol Cell Biol. 2008 Apr;28(7):2426-36
pubmed: 18227151
J Clin Invest. 2005 Jan;115(1):56-65
pubmed: 15630444
Cell. 2016 Dec 1;167(6):1525-1539.e17
pubmed: 27912060
Gastroenterology. 2014 Oct;147(4):765-783.e4
pubmed: 25046161
Curr Biol. 2007 Dec 4;17(23):2054-60
pubmed: 17980593
Nat Commun. 2016 Jun 30;7:11961
pubmed: 27358050
Hepatology. 2015 Mar;61(3):1066-79
pubmed: 25066777
Nat Rev Cancer. 2013 Apr;13(4):246-57
pubmed: 23467301
J Lipid Res. 2013 Jan;54(1):44-54
pubmed: 23071295
Cell Stem Cell. 2014 Nov 6;15(5):605-18
pubmed: 25312494
Gut. 2018 Sep;67(9):1692-1703
pubmed: 28866620
Chromosome Res. 2016 Jan;24(1):93-104
pubmed: 26582635

Auteurs

Meghan Mooring (M)

Division of Gastroenterology and Nutrition, Department of Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA.

Brendan H Fowl (BH)

Division of Gastroenterology and Nutrition, Department of Pediatrics, Boston Children's Hospital, Boston, MA.

Shelly Z C Lum (SZC)

Division of Gastroenterology and Nutrition, Department of Pediatrics, Boston Children's Hospital, Boston, MA.

Ye Liu (Y)

Division of Gastroenterology and Nutrition, Department of Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA.

Kangning Yao (K)

Division of Gastroenterology and Nutrition, Department of Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA.

Samir Softic (S)

Division of Gastroenterology and Nutrition, Department of Pediatrics, Boston Children's Hospital, Boston, MA.
Section on Integrative Physiology and Metabolism, Joslin Diabetes Center and Department of Medicine, Harvard Medical School, Boston, MA.

Rory Kirchner (R)

Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.

Aaron Bernstein (A)

Department of Developmental, Molecular, and Chemical Biology, School of Medicine, Tufts University, Boston, MA.

Aatur D Singhi (AD)

Pittsburgh Liver Research Center, University of Pittsburgh/University of Pittsburgh Medical Center, Pittsburgh, PA.

Daniel G Jay (DG)

Department of Developmental, Molecular, and Chemical Biology, School of Medicine, Tufts University, Boston, MA.

C Ronald Kahn (CR)

Section on Integrative Physiology and Metabolism, Joslin Diabetes Center and Department of Medicine, Harvard Medical School, Boston, MA.

Fernando D Camargo (FD)

The Stem Cell Program, Boston Children's Hospital, Boston, MA.
Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA.

Dean Yimlamai (D)

Division of Gastroenterology and Nutrition, Department of Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA.
Division of Gastroenterology and Nutrition, Department of Pediatrics, Boston Children's Hospital, Boston, MA.
Pittsburgh Liver Research Center, University of Pittsburgh/University of Pittsburgh Medical Center, Pittsburgh, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH